{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:20:22Z","timestamp":1783617622104,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T00:00:00Z","timestamp":1187136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1471-2407-7-160","type":"journal-article","created":{"date-parts":[[2007,8,15]],"date-time":"2007-08-15T18:13:35Z","timestamp":1187201615000},"source":"Crossref","is-referenced-by-count":52,"title":["Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH): study protocol"],"prefix":"10.1186","volume":"7","author":[{"name":"the POSH steering group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Eccles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Gerty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Simmonds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G","family":"Altman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,15]]},"reference":[{"key":"810_CR1","unstructured":"Cancer Research UK. [\n                    http:\/\/info.cancerresearchuk.org\/cancerstats\/types\/breast\/\n                    \n                  ]"},{"key":"810_CR2","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/cncr.21070","volume":"103","author":"AM Gonzalez-Angulo","year":"2005","unstructured":"Gonzalez-Angulo AM, Broglio K, Kau SW, Eralp Y, Erlichman J, Valero V, et al: Women age < or = 35 years with primary breast carcinoma: disease features at presentation. Cancer. 2005, 103: 2466-2472. 10.1002\/cncr.21070.","journal-title":"Cancer"},{"key":"810_CR3","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdl145","volume":"10","author":"M Colleoni","year":"2006","unstructured":"Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Orlando L, Ghisini R, et al: Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol. 2006, 10: 1497-1503. 10.1093\/annonc\/mdl145.","journal-title":"Ann Oncol"},{"key":"810_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1524-4741.2001.20012.x","volume":"7","author":"DM Euhus","year":"2001","unstructured":"Euhus DM: Understanding mathematical models for breast cancer risk assessment and counseling. Breast J. 2001, 7: 224-232. 10.1046\/j.1524-4741.2001.20012.x.","journal-title":"Breast J"},{"key":"810_CR5","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nrc1476","volume":"4","author":"PD Pharoah","year":"2004","unstructured":"Pharoah PD, Dunning AM, Ponder BA, Easton DF: Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer. 2004, 4: 850-860. 10.1038\/nrc1476.","journal-title":"Nat Rev Cancer"},{"key":"810_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ng1959","volume":"39","author":"N Rahman","year":"2007","unstructured":"Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, et al: PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet. 2007, 39: 165-167. 10.1038\/ng1959.","journal-title":"Nat Genet"},{"key":"810_CR7","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/ng1837","volume":"38","author":"A Renwick","year":"2006","unstructured":"Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, et al: ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet. 2006, 38: 873-875. 10.1038\/ng1837.","journal-title":"Nat Genet"},{"key":"810_CR8","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, et al: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006, 38: 1239-1241. 10.1038\/ng1902.","journal-title":"Nat Genet"},{"key":"810_CR9","volume-title":"Nature","author":"DF Easton","year":"2007","unstructured":"Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature. 2007"},{"key":"810_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10549-004-1536-0","volume":"90","author":"J Palacios","year":"2005","unstructured":"Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A, et al: Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat. 2005, 90: 5-14. 10.1007\/s10549-004-1536-0.","journal-title":"Breast Cancer Res Treat"},{"key":"810_CR11","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1200\/JCO.2005.01.3698","volume":"23","author":"E Honrado","year":"2005","unstructured":"Honrado E, Osorio A, Palacios J, Milne RL, Sanchez L, Diez O, et al: Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors. J Clin Oncol. 2005, 23: 7503-7511. 10.1200\/JCO.2005.01.3698.","journal-title":"J Clin Oncol"},{"key":"810_CR12","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1158\/1078-0432.CCR-04-2424","volume":"11","author":"SR Lakhani","year":"2005","unstructured":"Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van d V, Parry S, et al: Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res. 2005, 11: 5175-5180. 10.1158\/1078-0432.CCR-04-2424.","journal-title":"Clin Cancer Res"},{"key":"810_CR13","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/bjs.1800811038","volume":"81","author":"DE Porter","year":"1994","unstructured":"Porter DE, Cohen BB, Wallace MR, Smyth E, Chetty U, Dixon JM, et al: Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg. 1994, 81: 1512-1515. 10.1002\/bjs.1800811038.","journal-title":"Br J Surg"},{"key":"810_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1053\/ctrv.2001.0233","volume":"27","author":"MO Nicoletto","year":"2001","unstructured":"Nicoletto MO, Donach M, De NA, Artioli G, Banna G, Monfardini S: BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling. Cancer Treat Rev. 2001, 27: 295-304. 10.1053\/ctrv.2001.0233.","journal-title":"Cancer Treat Rev"},{"key":"810_CR15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0140-6736(97)07065-7","volume":"351","author":"LC Verhoog","year":"1998","unstructured":"Verhoog LC, Brekelmans CT, Seynaeve C, van den Bosch LM, Dahmen G, van Geel AN, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet. 1998, 351: 316-321. 10.1016\/S0140-6736(97)07065-7.","journal-title":"Lancet"},{"key":"810_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1023\/A:1013867917101","volume":"1","author":"D Eccles","year":"2001","unstructured":"Eccles D, Simmonds P, Goddard J, Coultas M, Hodgson S, Lalloo F, et al: Familial breast cancer: An investigation into the outcome of treatment for early stage disease. Familial Cancer. 2001, 1: 72-10.1023\/A:1013867917101.","journal-title":"Familial Cancer"},{"key":"810_CR17","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1200\/JCO.1998.16.2.397","volume":"16","author":"OT Johannsson","year":"1998","unstructured":"Johannsson OT, Ranstam J, Borg A, Olsson H: Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol. 1998, 16: 397-404.","journal-title":"J Clin Oncol"},{"key":"810_CR18","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1200\/JCO.2000.18.24.4053","volume":"18","author":"D Stoppa-Lyonnet","year":"2000","unstructured":"Stoppa-Lyonnet D, Ansquer Y, Dreyfus H, Gautier C, Gauthier-Villars M, Bourstyn E, et al: Familial invasive breast cancers: worse outcome related to BRCA1 mutations. J Clin Oncol. 2000, 18: 4053-4059.","journal-title":"J Clin Oncol"},{"key":"810_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0092-8674(02)00615-3","volume":"108","author":"AR Venkitaraman","year":"2002","unstructured":"Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002, 108: 171-182. 10.1016\/S0092-8674(02)00615-3.","journal-title":"Cell"},{"key":"810_CR20","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/ng1902","volume":"38","author":"S Seal","year":"2006","unstructured":"Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, et al: Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet. 2006, 38: 1239-1241. 10.1038\/ng1902.","journal-title":"Nat Genet"},{"key":"810_CR21","first-page":"6221","volume":"63","author":"JE Quinn","year":"2003","unstructured":"Quinn JE, Kennedy RD, Mullan PB, Gilmore PM, Carty M, Johnston PG, et al: BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. Cancer Res. 2003, 63: 6221-6228.","journal-title":"Cancer Res"},{"key":"810_CR22","first-page":"63","volume":"1","author":"DM Eccles","year":"2006","unstructured":"Eccles DM, Simmonds P: Clinical Management in Hereditary Breast Cancer. Cancer & Chemotherapy Reviews. 2006, 1: 63-69.","journal-title":"Cancer & Chemotherapy Reviews"},{"key":"810_CR23","unstructured":"POSH study website. [\n                    http:\/\/www.som.soton.ac.uk\/research\/cancersciences\/Research_Groups\/Cancer_genetics\/POSH\/default.htm\n                    \n                  ]"},{"key":"810_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/bmj.321.7252.28","volume":"321","author":"J Emery","year":"2000","unstructured":"Emery J, Walton R, Murphy M, Austoker J, Yudkin P, Chapman C, et al: Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ. 2000, 321: 28-32. 10.1136\/bmj.321.7252.28.","journal-title":"BMJ"},{"key":"810_CR25","first-page":"232","volume":"48","author":"EB Claus","year":"1991","unstructured":"Claus EB, Risch N, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet. 1991, 48: 232-242.","journal-title":"Am J Hum Genet"},{"key":"810_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1136\/jmg.40.11.807","volume":"40","author":"E Amir","year":"2003","unstructured":"Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, et al: Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet. 2003, 40: 807-814. 10.1136\/jmg.40.11.807.","journal-title":"J Med Genet"},{"key":"810_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","volume":"21","author":"SM Domchek","year":"2003","unstructured":"Domchek SM, Eisen A, Calzone K, Stopfer J, Blackwood A, Weber BL: Application of breast cancer risk prediction models in clinical practice. J Clin Oncol. 2003, 21: 593-601. 10.1200\/JCO.2003.07.007.","journal-title":"J Clin Oncol"},{"key":"810_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/sj.bjc.6603358","volume":"95","author":"HH Kang","year":"2006","unstructured":"Kang HH, Williams R, Leary J, Ringland C, Kirk J, Ward R: Evaluation of models to predict BRCA germline mutations. Br J Cancer. 2006, 95: 914-920. 10.1038\/sj.bjc.6603358.","journal-title":"Br J Cancer"},{"key":"810_CR29","first-page":"AS8","volume":"33","author":"LE Moses","year":"1995","unstructured":"Moses LE: Measuring effects without randomized trials? Options, problems, challenges. Med Care. 1995, 33: AS8-14.","journal-title":"Med Care"},{"key":"810_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1470-2045(05)70318-1","volume":"6","author":"DM Eccles","year":"2005","unstructured":"Eccles DM, Pichert G: Familial non-BRCA1\/BRCA2-associated breast cancer. Lancet Oncol. 2005, 6: 705-711. 10.1016\/S1470-2045(05)70318-1.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-7-160\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-160","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-7-160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:14:17Z","timestamp":1548108857000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-7-160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,15]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["810"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-7-160","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,15]]},"article-number":"160"}}